Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,234 | -3,699 | -2,188 | -874 | -3,806 |
| Depreciation Amortization | 230 | 195 | 164 | 135 | 92 |
| Accounts receivable | 636 | 668 | 545 | 442 | -249 |
| Other Working Capital | -109 | -163 | 345 | -441 | 2,267 |
| Other Operating Activity | -268 | -402 | -329 | -260 | 1,139 |
| Operating Cash Flow | $-5,745 | $-3,400 | $-1,462 | $-998 | $-558 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,610 | -8,395 | -11,868 | -2,200 | -400 |
| PPE Investments | -260 | -179 | -81 | -52 | -10 |
| Investing Cash Flow | $-18,870 | $-8,574 | $-11,949 | $-2,252 | $-410 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,926 | 18,541 | 18,540 | 18,470 | 4,690 |
| Financing Cash Flow | $28,926 | $18,541 | $18,540 | $18,470 | $4,690 |
| Beginning Cash Position | 4,847 | 4,847 | 4,847 | 4,847 | 1,125 |
| End Cash Position | 9,157 | 11,414 | 9,977 | 20,067 | 4,847 |
| Net Cash Flow | $4,310 | $6,567 | $5,130 | $15,220 | $3,722 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,745 | -3,400 | -1,462 | -998 | -558 |
| Capital Expenditure | -260 | -179 | -81 | -52 | -10 |
| Free Cash Flow | -6,005 | -3,579 | -1,543 | -1,050 | -568 |